Eric Lorent is a Principal Scientist in Early-CMC Analytics at Sanofi Ghent, having progressed through various scientific roles since starting their career. They began as a Doctoral student at Innogenetics from 2002 to 2007, focusing on the structural characterization of the hepatitis C envelope protein. They further advanced their expertise during a post-doctoral position at VIB, SWITCH laboratory, where they validated the concept of Alphabodies. Eric served as Group Leader at Complix N.V. from 2010 to 2018 and later as a Scientist at Ablynx from 2018 to 2021. They completed their Master's in Biochemistry and Ph.D. at KU Leuven, which laid the foundation for their extensive career in biochemistry and protein analysis.
This person is not in the org chart
This person is not in any teams
This person is not in any offices